[Preliminary results and complications of HCV treatment after liver transplantation].
The aim of study was to report the preliminary results and complications of HCV infection treatment after liver transplantation.


METHODS
Six patients after liver transplantation (one after combine liver and kidney) had been qualified to treatment with pegylated interferon and ribavirin.


RESULTS
In four patients the therapy was discontinued due to severe side effects (anaemia, cholestasis, sepsis, acute rejection). In two patients the normalization of biochemical parameters of liver function was achived after treatment.


CONCLUSIONS
HCV treatement in solid organ recipients should be individualised.
Klinika Gastroenterologii, Hepatologii i Immunologii. j.pawlowska@czd.pl
Joanna
J
Pawłowska
Mikołaj
M
Teisseyre
Irena
I
Jankowska
Piotr
P
Kaliciński
Katarzyna
K
Dzierzanowska-Fangrat
Przemysław
P
Kluge
Joanna
J
Teisseyre
Jerzy
J
Socha
Marek
M
Woynarowski
D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D016031:Liver Transplantation; D008297:Male; D011092:Polyethylene Glycols; D011183:Postoperative Complications / Q000139:chemically induced*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*; D016896:Treatment Outcome
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b